Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TraumaCad Neo

K-Number: K231498 · 2023-11-20

ApplicantBrainlab , Ltd.
Decision Date2023-11-20
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

TraumaCad Neo is a medical device manufactured by Brainlab , Ltd.. It received FDA 510(k) clearance on 2023-11-20 under approval number K231498. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TraumaCad Neo?

TraumaCad Neo is a medical device that received FDA 510(k) clearance on 2023-11-20. It is manufactured by Brainlab , Ltd.. The 510(k) number is K231498.

When was TraumaCad Neo approved by the FDA?

TraumaCad Neo received FDA 510(k) clearance on 2023-11-20, under approval number K231498.

What company makes TraumaCad Neo?

TraumaCad Neo is manufactured by Brainlab , Ltd..

What is the FDA product code for TraumaCad Neo?

The FDA product code for TraumaCad Neo is LLZ.

Other Devices by Brainlab , Ltd.

K243810TraumaCad Neo (1.1)

Related Devices (Code: LLZ)

K161959ClearView cCADClearview Diagnostics, Inc. K163539Ez3D-i / E3Ewoosoft Co., Ltd. K162955Multi-Modality Tumor Tracking (MMTT) applicationPhilips Medical Systems Nederland B.V. K160852ZiaZetta Medical Technologies, LLC K162376CAAS MR 4D FlowPie Medical Imaging BV K161322CT CoPilotZepmed, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑